首页 | 本学科首页   官方微博 | 高级检索  
     

支气管哮喘患儿血清25羟维生素D3水平变化及补充维生素D治疗对患儿发病、预后的影响研究
引用本文:程培培,周启立,任磊,张丽然,刘伟. 支气管哮喘患儿血清25羟维生素D3水平变化及补充维生素D治疗对患儿发病、预后的影响研究[J]. 临床和实验医学杂志, 2021, 20(3): 323-326
作者姓名:程培培  周启立  任磊  张丽然  刘伟
作者单位:承德医学院附属医院小儿内科 河北承德067000;承德医学院附属医院小儿内科 河北承德067000;承德医学院附属医院小儿内科 河北承德067000;承德医学院附属医院小儿内科 河北承德067000;承德医学院附属医院小儿内科 河北承德067000
基金项目:承德市科技支撑计划项目(201701A074);河北省卫计委2016年重点课题计划项目(编号:20160017)。
摘    要:目的 探讨分析支气管哮喘患儿血清25羟维生素D3( 25 - OH - D3 )水平变化及补充维生素D治疗对患儿发病、预后的影响.方法 回顾性选择2016年1月至2019年1月承德医学院附属医院收治的200例支气管哮喘患儿为研究对象,设为A组,同时选择200例呼吸道感染的非支气管哮喘患儿、200名体检健康儿童分别设为B...

关 键 词:儿童  支气管哮喘  25羟维生素D3  维生素D  发病  预后

Study on the changes of serum 25-Hydroxyvitamin D3 level in children with bronchial asthma and the effect of vitamin D supplementation on the incidence and prognosis of children
Affiliation:(Department of Pediatrics,Affiliated Hospital of Chengde Medical College,Chengde Hebei 067000,China.)
Abstract:Objective To investigate and analyze the changes of serum 25-hydroxyvitamin D3(25-OH-D3)levels in children with bronchial asthma and the effect of vitamin D supplementation on the onset and prognosis of children.Methods 200 children with bronchial asthma admitted to Affiliated Hospital of Chengde Medical College from January 2016 to January 2019 were selected as the research objects,and set as group A.At the same time,200 children with non-bronchial asthma with respiratory infections and 200 healthy children with physical examination were selected.Set as group B and group C;observe and compare the differences in serum 25-OH-D3 levels in groups A,B,and C;at the same time,children in group A were randomly divided into study group(n=100)and control group(n=100).The control group was given conventional treatment,and the study group was given vitamin D treatment on the basis of the control group.The changes in serum 25-OH-D3 levels before and after treatment were observed and compared between the two groups of children.The number of attacks,the severity of the disease and the number of hospitalizations.Results Serum 25-OH-D3 levels in group A,group B and group C were(20.26±3.75)μg/L,(36.98±4.26)μg/L,(37.15±4.39)μg/L,respectively.The serum 25-OH-D3 level of group A was significantly lower than that of group B and group C,the difference was statistically significant(P<0.05),while the serum 25-OH-D3 level of group B and C had no significant difference(P>0.05).Serum 25-OH-D3 levels before treatment between the study group and the control group were not significantly different[(20.07±3.48)μg/L vs.(20.39±3.78)μg/L](P>0.05);after treatment in the study group,the serum 25-OH-D3 level was(34.28±4.18)μg/L,which was significantly higher than that of the control group(24.89±3.65)μg/L,the difference was statistically significant(P<0.05).Follow-up for 1 year,the number of attacks and hospitalizations in the study group were significantly less than those in the control group[(1.01±0.23)vs.(2.23±0.54),(0.32±0.08)vs.(1.03±0.24)](P<0.05),the number of severe asthma attacks/attack was significantly lower than that of the control group[(0.28±0.06)vs.(0.41±0.11)],the difference was statistically significant(P<0.05).Conclusion The serum 25-OH-D3 level of children with bronchial asthma is significantly reduced.Vitamin D supplementation can significantly increase the serum 25-OH-D3 level of the children,reduce the number of attacks and hospitalizations,and reduce the severity of the disease.
Keywords:Children  Bronchial asthma  25-OH-D3  Vitamin D  Onset  Prognosis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号